Every now and then, The New York Times takes a big ol' swipe at derivatives for being evil and whatnot. That's fine and well -- and sometimes obligatory, particularly when it comes to certain structured products for which it's hard to discern the benefit to anyone outside of a bank.
But it can all go awry when someone starts arguing against derivatives and just gets it wrong. It makes us do a sad, frowny face and then get incredibly frustrated.
The Morning Email helps you start your workday with everything you need to know: breaking news, entertainment and a dash of fun. Learn more